AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Apyx Medical Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 14, 2019

LOS ANGELES--(BUSINESS WIRE)--Jun 14, 2019--

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Apyx Medical Corporation (“Apyx” or “the Company”) (NASDAQ: APYX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. The clinical study of Apyx’s J-Plasma for dermal resurfacing did not reach its primary efficacy endpoint. The study did not support the Company’s application for regulatory clearance. In fact, Apyx was unlikely to receive approval for the use of J-Plasma in dermal resurfacing. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Apyx, investors suffered damages.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at  www.schallfirm.com, or by email at  brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190614005392/en/

CONTACT: The Schall Law Firm

Brian Schall, Esq.

310-301-3335

Cell: 424-303-1964

info@schallfirm.com

www.schallfirm.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL

SOURCE: The Schall Law Firm

Copyright Business Wire 2019.

PUB: 06/14/2019 12:30 PM/DISC: 06/14/2019 12:30 PM

http://www.businesswire.com/news/home/20190614005392/en

All contents © copyright 2019 The Associated Press. All rights reserved.